HC Wainwright Cuts Price Target On This Stock By 73%, Also Check Out Other Major PT Changes Here

  • Susquehanna cut the price target on Baidu, Inc. BIDU from $200 to $195. Susquehanna analyst Shyam Patil maintained the stock with a Positive rating. Baidu shares rose 0.7% to $139.38 in pre-market trading.
  • Morgan Stanley lowered the price target for Celularity Inc. CELU from $8 to $5. Morgan Stanley analyst Jeffrey Hung maintained the stock with an Equal-Weight. Celularity shares rose 1.6% to $2.50 on Friday.
  • BMO Capital raised the price target on Bristol-Myers Squibb Company BMY from $92 to $94. Bristol-Myers Squibb shares rose 6.9% to $75.01 in pre-market trading.
  • Piper Sandler boosted the price target for Comerica Incorporated CMA from $90 to $94. Comerica shares rose 0.1% to $84.57 in pre-market trading.
  • Wells Fargo cut the price target on Charter Communications, Inc. CHTR from $393 to $370. Charter Communications shares rose 0.1% to $406.05 in pre-market trading.
  • Barclays cut the price target for Thermo Fisher Scientific Inc. TMO from $685 to $595. Thermo Fisher Scientific shares rose 0.8% to $573.99 in pre-market trading.
  • HC Wainwright & Co. lowered the price target on Neoleukin Therapeutics, Inc. NLTX from $22 to $6. Neoleukin Therapeutics shares jumped 5.8% to close at $1.09 on Friday.

Check out this: Bristol-Myers Squibb, Carvana And Some Other Big Stocks Recording Gains In Today's Pre-Market Session

Don’t forget to check out our premarket coverage here .

Market News and Data brought to you by Benzinga APIs
Price Target
Posted In: NewsPenny StocksPrice TargetSmall CapPre-Market OutlookMarketsAnalyst RatingsPT Changes
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!